Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in Inventory
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Cash from Operations (2022 - 2023)

Historic Cash from Operations for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to -$4.7 million.

  • Mainz Biomed's Cash from Operations rose 121.3% to -$4.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$21.9 million, marking a year-over-year decrease of 4854.07%. This contributed to the annual value of -$17.1 million for FY2024, which is 2210.16% up from last year.
  • Per Mainz Biomed's latest filing, its Cash from Operations stood at -$4.7 million for Q4 2023, which was up 121.3% from -$6.5 million recorded in Q3 2023.
  • Mainz Biomed's Cash from Operations' 5-year high stood at -$2.8 million during Q1 2022, with a 5-year trough of -$6.5 million in Q3 2023.